We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

215 hedge funds and large institutions have $2.47B invested in Arena Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

31% more capital invested

Capital invested by funds: $1.88B → $2.47B (+$586M)

19% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $16.4M

17% more funds holding

Funds holding: 184 → 215 (+31)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
215
Holders Change
+31
Holders Change %
+16.85%
% of All Funds
4.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
69
Reduced
43
Closed
23
Calls
$19.5M
Puts
$16.4M
Net Calls
+$3.06M
Net Calls Change
-$6.54M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
2
N
Nuveen
North Carolina
+$23.4M
3
EMG
ETF Managers Group
New Jersey
+$20.9M
4
Invesco
Invesco
Georgia
+$11.2M
5
MCM
Matarin Capital Management
New York
+$10.7M

Top Sellers

1
PHS
PFM Health Sciences
California
-$73.7M
2
RCMNY
Rubric Capital Management (New York)
New York
-$38.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$16.7M
4
MWNA
Marshall Wace North America
New York
-$16.5M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
USAA
76
United Services Automobile Association
Texas
$2.99M +$92K +1,781 +4%
BG
77
Bellevue Group
Switzerland
$2.75M – – –
Squarepoint
78
Squarepoint
New York
$2.65M +$1.31M +25,339 +128%
FLAM
79
First Light Asset Management
Minnesota
$2.62M +$2.31M +44,704 New
Skandinaviska Enskilda Banken (SEB)
80
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.62M +$2.31M +44,600 New
Morgan Stanley
81
Morgan Stanley
New York
$2.43M -$3.46M -66,980 -62%
UBS AM
82
UBS AM
Illinois
$2.38M +$166K +3,221 +9%
MSL
83
Mackay Shields LLC
New York
$2.37M +$1.2M +23,289 +135%
PPA
84
Parametric Portfolio Associates
Washington
$2.31M +$1.77M +34,231 +652%
Massachusetts Financial Services
85
Massachusetts Financial Services
Massachusetts
$2.27M +$2M +38,775 New
Ameriprise
86
Ameriprise
Minnesota
$2.26M +$790K +15,289 +66%
Renaissance Technologies
87
Renaissance Technologies
New York
$1.92M +$1.7M +32,816 New
AIG
88
American International Group
New York
$1.86M +$5.89K +114 +0.4%
Manulife (Manufacturers Life Insurance)
89
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.81M -$72.6K -1,405 -4%
ACM
90
AlphaCrest Capital Management
New York
$1.75M +$1.54M +29,800 New
Citigroup
91
Citigroup
New York
$1.71M +$594K +11,500 +65%
Capital Fund Management (CFM)
92
Capital Fund Management (CFM)
France
$1.65M +$1.45M +28,145 New
Marshall Wace
93
Marshall Wace
United Kingdom
$1.64M +$1.19M +23,101 +467%
TCM
94
Tekla Capital Management
Massachusetts
$1.64M -$1.25M -24,260 -46%
SEC
95
Seven Eight Capital
New York
$1.61M +$1.42M +27,479 New
Schroder Investment Management Group
96
Schroder Investment Management Group
United Kingdom
$1.58M +$1.39M +26,972 New
EAM
97
Erste Asset Management
Austria
$1.53M +$517K +10,000 +61%
Legal & General Group
98
Legal & General Group
United Kingdom
$1.51M +$286K +5,530 +27%
Balyasny Asset Management
99
Balyasny Asset Management
Illinois
$1.51M +$1.33M +25,692 New
VRS
100
Virginia Retirement Systems
Virginia
$1.5M +$196K +3,800 +18%
2 3
4
5 6

ARNA Hedge Fund Activity: Q2 2019 in Review

215 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2019, worth a combined $2.47B — up 31% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ARNA positions and 23 closed out — a net gain of 35 holders — while 69 added to existing stakes and 43 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $50.6M. The largest seller was PFM Health Sciences, cutting an estimated $73.7M.

  • 215 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2019, up from 184 in Q1 2019.
  • Funds reported $2.47B of Arena Pharmaceuticals Inc stock for Q2 2019, up 31% quarter-over-quarter.
  • 58 funds opened new Arena Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of +35 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2019 was AllianceBernstein, an estimated $50.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2019 was PFM Health Sciences, an estimated $73.7M sold.

Based on aggregated 13F filings for Q2 2019.